Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208
Published November 4, 2020 · Recall initiated: September 14, 2020
Summary
FDA records medical device Class II recall Z-0295-2021, published November 4, 2020 and initiated September 14, 2020. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 72 units; Lot: Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Becton Dickinson & Company
- Distributor
- Foreign: Italy, Spain, and UK
- Lot
- Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDAPhilips Sterilizable Defibrillator Paddles, Switched Internal Paddles, Model Numbers M4741A, M4742A, M4743A,November 4, 2020
- FDA5.5MM Arthrogarde Hip Access CannulaNovember 4, 2020
Questions about this recall
Was Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208 recalled?
Yes. FDA published recall Z-0295-2021 on November 4, 2020. Reported hazard: Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail